Although GLP-1 medications are relatively new, several areas of research are generating excitement among lymphatic specialists
Spielmans GI, Berman MI, Linardatos E, Rosenlicht NZ, Perry A, Tsai AC
While some plans cover Wegovy, other plans are more restrictive
On Wednesday, the Food and Drug Administration issued a warning, calling compounded GLP-1 medications "risky for patients." "FDA is aware that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs, including semaglutide and tirzepatide, as an option for weight loss," the FDA said
Standard oral absorption issues include: Enzymatic degradation: The GGT enzyme in the gut lining breaks the glutathione molecule apart